LAVA Therapeutics (LVTX)

• Market cap: $42.7M
• 1 day: 0%
• 5 days: 3.16%
• 1 month: 4.49%
• 3 months: 7.24%
• 6 months: 30.4%
• Year to date: 58.25%
• 1 year: -9.94%
• 5 years: -88.6%
• 10 years: -88.6%
• Sector: Healthcare
• Industry: Biotechnology

About: LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

Employees: 34